top of page

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Pivikto 150mg Tablet

Pivikto 150mg Tablet

Manufacturer/Marketed By : NOVARTIS INDIA LTD

$395.12 $368.43

Pivikto 150mg Tablet contains the active ingredient Alpelisib and belongs to the class of PI3K (phosphatidylinositol-3-kinase) inhibitors. It is primarily used in combination with other anticancer medications to treat metastatic...

ALPELISIB

Active Pharmaceutical Ingredient

Pivikto 150mg Tablet

SKU PIVIKTO-150MG-TABLET
Original price

$395.12

Sale price

$368.43

Pivikto 150mg Tablet contains the active ingredient Alpelisib and belongs to the class of PI3K (phosphatidylinositol-3-kinase) inhibitors. It is primarily used in combination with other anticancer medications to treat metastatic breast cancer in women who have undergone menopause or in men whose cancer progressed during or after other treatments. Pivikto is also indicated for certain types of PIK3CA-related overgrowth spectrum (PROS), a genetic condition that causes overgrowth and tissue abnormalities. Patients should follow Pivikto dosage instructions carefully and only take the medicine as prescribed by their healthcare provider. It is important to store the medication according to Pivikto storage instructions to maintain its efficacy. Use of Pivikto requires caution in individuals with kidney or liver issues, and patients should discuss these conditions with their doctor prior to starting therapy. Monitoring for potential side effects, including hyperglycemia, is recommended. For women who are pregnant or planning pregnancy, consult a physician regarding Pivikto pregnancy safety. While taking this medication, long-term use safety should be evaluated with regular follow-ups. Patients can purchase the medicine online with options like Buy Pivikto 150 online, and should be aware of available Pivikto alternatives. Pivikto is manufactured by Novartis India, and its Pivikto price India may vary depending on location and pharmacy.

Active Pharmaceutical Ingredient

ALPELISIB

Uses

• HER2- negative Breast cancer

Benefits

Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.

Side Effects

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Pivikto 150 side effects are

Most Common Side Effects

• Cellulitis
• Hyperglycemia
• Diarrhea
• Hypersensitivity reactions
• Pneumonitis
• Dehydration
• Angioedema

Common Side Effects

• Hair loss
• Decreased weight
• Decreased appetite
• Nausea, vomiting
• Tiredness

How To Use

Your doctor will decide the dose and duration of Pivikto 150mg tablet based on the disease condition and other factors. Always take this medicine as prescribed by your doctor. Take the tablet at the same time, immediately after food. Do not break, chew, crush, or break the tablet. Swallow the whole tablet with water. If you cannot swallow the tablet, mix the tablets into a glass of water as per doctor advice.

Safety Advice

• Breast Feeding: Breastfeeding is not recommended in patients taking Pivikto 150mg tablet because the medicine passes into the breast milk in small amounts and may harm your baby. Do not breastfeed during the treatment.
• Alcohol: It is not known whether it is safe to consume alcohol with Pivikto 150mg tablet. Please consult your doctor.
• Liver: Pivikto 150mg tablet is safe to use in patients with liver problems. There is no need for dose adjustments. Inform your physician if you have any liver disease before initiating the therapy.
• Lungs: It is unknown whether Pivikto 150mg tablet can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.
• Driving: Pivikto 150mg tablet may alter your ability to drive and operate heavy machinery. The treatment may cause tiredness hence avoid activities after taking the medicine.
• Pregnancy: Do not take Pivikto 150mg tablet if you are pregnant because this may harm the unborn baby. Inform your physician if you are pregnant, suspecting pregnancy, or planning to get pregnant during the treatment. Use effective contraception during the treatment and for 1 week after the last dose.

Disclaimer

Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.

Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.

All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.

Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.

bottom of page